Atlas Trials

Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

Clinical trial NCT03682289 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03682289
Sponsor
Rahul Aggarwal
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Clear Cell Renal Cell CarcinomaLocally Advanced Pancreatic CancerLocally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmMetastatic Renal Cell CarcinomaMetastatic Urothelial CarcinomaMetastatic Pancreatic CancerStage III Pancreatic CancerStage III Renal Cell CancerStage IV Pancreatic CancerStage IV Renal Cell CancerEndometrial Cancer
Start date
2019-01-17
Primary completion
2028-03-31
Enrollment
83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.